Government Bone Doctors Schedule Mystery Meeting About Something
Published Date: 12/12/2025
Notice
Summary
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is holding a virtual meeting on January 27, 2026, to discuss research updates and review grant applications. Anyone interested can watch the open session online, but the grant review part is private to protect sensitive info. This meeting affects researchers and organizations seeking funding and helps decide which projects get support.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Grant applications reviewed in closed session
If you are a researcher or organization applying for NIAMS funding, your grant applications will be reviewed privately on January 27, 2026 from 2:45 p.m. to 3:00 p.m. The session is closed under 5 U.S.C. 552b(c)(4) and (6) to protect confidential trade secrets, patentable material, and personal information.
Open session videocast available
You can watch the open portion of the NIAMS Advisory Council meeting online on January 27, 2026 from 9:30 a.m. to 2:45 p.m. The open session will be videocast at https://videocast.nih.gov/watch=57112 and registration is not required to view it.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-22673 — Agency Information Collection Activities: Comment Request; National Science Foundation (NSF) Innovation Corps (I-CorpsTM) Program Pre-submission Executive Summary Form
The National Science Foundation (NSF) is asking for public feedback on a form used by innovators applying to their I-Corps program. This form helps NSF understand new ideas before full proposals are submitted. Comments are open for 30 days, and this process won’t cost anyone money but aims to make the application smoother and clearer.
Next: 2025-22676 — Determination That ZANTAC (Ranitidine Hydrochloride) Injection, Equivalent to 25 Milligrams Base/Milliliter, Has Not Been Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that ZANTAC injection (25 mg/mL) hasn’t been pulled from the market because of safety or effectiveness problems. This means generic versions can keep getting approved as long as they meet safety rules, especially about tiny impurities. Patients and drug makers can breathe easy knowing ZANTAC injection stays available under strict quality checks.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in